Shantanu Jain

Shantanu Jain

Auto-generated profile, based on publicly available information

Shantanu Jain

Health City Hospital

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2026 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
SDSaurabhi Das
Saurabhi Das
SJShantanu Jain
Shantanu Jain
MKMirza Mohd Kamran
Mirza Mohd Kamran
SPSukanya Pathak
Sukanya Pathak
KSKangkan Sharma
Kangkan Sharma
NSNarendra Sharma
Narendra Sharma
Background: Percutaneous device closure is the preferred method for closing patent ductus arteriosus (PDA), even in preterm infants. We report our experience using the new KONAR-MFO™ ventricular septal defect occluder for transcatheter closure of preterm patent ductus arteriosus as an alternative device in resource-limited centres. Methodology: Case 1: A preterm baby with Down’s syndrome and tracheobronchomalacia was born at 29 weeks, weighing 1.68 kg with multiple cardiac defects, including a 4 mm PDA and a 6 mm mid-muscular ventricular septal defect (VSD), stuck on a ventilator. Case 2: Another preterm baby born at 35 weeks, weighing 1.89 kg, with anorectal malformation and a right inguinal hernia. The echocardiogram revealed a 4 mm PDA with severe PAH. In both cases, the patent ductus arteriosus was occluded using a 6 mm × 4 mm Konar MFO device on day 14 (case 1) and day 20 (case 2). Results: The baby (case 1) was weaned off the ventilator and discharged on the 28th postnatal day at 2.09 kg. As for case 2, the baby was weaned off the ventilator within 2 days and discharged on day 30 at 2.23 kg. A follow-up echocardiogram of both cases confirmed a well-positioned device with no obstructions. At 18 months, in the follow-up, both babies were gaining weight and thriving. Conclusions: The KONAR MFO device is a safe and effective option for patent ductus arteriosus closure in preterm infants, even in resource-limited settings. Its versatility accommodates various duct sizes and morphologies, and its self-expandable design ensures easy deployment, addressing the anatomical challenges often seen in preterm infants.

9 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SDSaurabhi Das
Saurabhi Das
SJShantanu Jain
Shantanu Jain
BackgroundAcute severe hemolysis following atrial septal defect (ASD) device closure is extremely rare, with precise incidence, underlying etiologies, and optimal management strategies remain inadequately understood.Case SummaryWe report a case of significant hemolysis after transcatheter ASD closure in 10 year old female, possibly related to the interface between the device surface and the high velocity jet of valvular regurgitation. Although many instances require device retrieval, in our case, hemolysis was conservatively managed with fluids, diuresis, corticosteroids and sodium bicarbonate and was discharged successfully on the 6th post-procedure day. In this case report, we aim to showcase the pathophysiology and management of acute severe hemolysis that occurred after ASD device closure.ConclusionBy sharing our clinical experience and discussing potential risk factors associated with this serious complication, we aspire to provide valuable insights that may reform future clinical practices and enhance preventive measures.

30 September 2026 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
SDSaurabhi Das
Saurabhi Das
SJShantanu Jain
Shantanu Jain
FAFaruk Abdullah
Faruk Abdullah
Acute severe haemolysis following atrial septal defect(ASD) device closure is extremely rare, where precise incidence, underlying aetiologies, and optimal management strategies remain inadequately understood. We report a case of significant haemolysis after transcatheter atrial septal defect closure in 10 year old female, possibly related to the interface between the device surface and the high-velocity jet of valvular regurgitation resulting from the abnormal configuration of the device. The presence of a residual shunt, combined with atrioventricular valve regurgitation flow, places pressure on the occluder’s discs, leading to increased erythrocyte fragility and subsequent rupture. In our case, haemolysis was initially conservatively managed with fluids, diuresis, and sodium bicarbonate, and the patient was discharged successfully on the 6 th post-procedure day. Surgical retrieval was advised; however, the patient was subsequently lost to follow-up. In this case report, we aim to showcase the pathophysiology, technical pitfalls regarding the procedure and management of acute severe haemolysis that occurred after atrial septal defect device closure. In conclusion, by sharing our clinical experiences and addressing misconceptions and potential risk factors for this serious complication, we aim to provide insights that may enhance future clinical practice and preventive strategies.

20 April 2026 in The American Journal of Cardiology
Verified
Journal Article
Closed access
SDSaurabhi Das
Saurabhi Das
SJShantanu Jain
Shantanu Jain
NSNarendra Sharma
Narendra Sharma

27 February 2026 in The Egyptian Heart Journal
Verified
Journal Article
Open access
PDF file
SDSaurabhi Das
Saurabhi Das
SJShantanu Jain
Shantanu Jain
NRNayem Raja
Nayem Raja
NSNarendra Sharma
Narendra Sharma
Background: Outlet septum ventricular septal defects (VSDs) are notably more prevalent in North-Eastern India and often associated with aortic valve prolapse, leading to a need for surgical intervention. While surgical methods remain the conventional approach, there is an opportunity to explore the effectiveness of transcatheter closure techniques. Objective and Methodology: This study aimed to assess the effectiveness and follow-up of transcatheter closure for outlet and outlet muscular type VSDs using three distinct devices: Amplatzer ADO II, KONAR MF VSD Occluder, and Cocoon VSD Occluder. This Descriptive study with follow-up observation up to 1 year was conducted at Health City Hospital in Guwahati, India, from March 2023 to November 2025, involving 21 patients who met the criteria for inclusion. Results: Among the 21 patients, transcatheter closure was successfully achieved in 16 individuals, resulting in a success rate of 76.2%. The mean diameter of the VSDs was 3.8 mm, with 66.6% of the cases showing pre-existing aortic valve prolapse. Closure attempts were unsuccessful in five patients, who subsequently received surgical intervention. In the successful cases, the Amplatzer ADO II was implanted in 7 patients (43.7%), the KONAR MFO in 8 patients (50%), and the Cocoon VSD occluder in 1 patient (6.3%). Seven patients exhibited mild intra-device residual shunts, and 37.5% (6/16) experienced a transient increase in aortic regurgitation (AR) after 24 hours post-procedure. Importantly, follow-up after one year showed static or non-progression of pre-existing AR, with worsening of AR (moderate severity) observed only in one patient, and the majority of residual shunts resolved. No major complications like outflow obstruction or device embolization were reported in the present study. Conclusion: The results indicate that transcatheter closure of outlet and outlet muscular type VSDs is a promising option for selected patients, yielding positive short- to mid-term outcomes. Further long-term follow-up will enhance our understanding of the procedure’s safety and efficacy, paving the way for broader application of this technique in clinical practice.